David A. Fox

David A. Fox

University of Michigan

H-index: 73

North America-United States

About David A. Fox

David A. Fox, With an exceptional h-index of 73 and a recent h-index of 41 (since 2020), a distinguished researcher at University of Michigan, specializes in the field of Rheumatology, Immunology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Siponimod Attenuates Neuronal Cell Death Triggered by Neuroinflammation via NFκB and Mitochondrial Pathways

Activation of cytotoxic lymphocytes through CD6 enhances killing of cancer cells

Challenges and promise of targeting miRNA in rheumatic diseases: A computational approach to identify miRNA association with cell types, cytokines, and disease mechanisms

New molecular targets in the treatment of rheumatoid arthritis

Rheumatoid arthritis–the challenge of heterogeneity

CD6 triggers actomyosin cytoskeleton remodeling after binding to its receptor complex

A CD6-targeted antibody-drug conjugate as a potential therapy for T cell–mediated disorders

Reporting and Establishment of Reference Intervals for Antiphospholipid Antibody Immunoassays: A Survey of Participants in the College of American Pathologists Proficiency …

David A. Fox Information

University

Position

Professor The

Citations(all)

19872

Citations(since 2020)

6236

Cited By

15547

hIndex(all)

73

hIndex(since 2020)

41

i10Index(all)

192

i10Index(since 2020)

115

Email

University Profile Page

University of Michigan

Google Scholar

View Google Scholar Profile

David A. Fox Skills & Research Interests

Rheumatology

Immunology

Top articles of David A. Fox

Title

Journal

Author(s)

Publication Date

Siponimod Attenuates Neuronal Cell Death Triggered by Neuroinflammation via NFκB and Mitochondrial Pathways

International Journal of Molecular Sciences

Mikel Gurrea-Rubio

Qin Wang

Elizabeth A Mills

Qi Wu

David Pitt

...

2024/2/20

Activation of cytotoxic lymphocytes through CD6 enhances killing of cancer cells

Cancer Immunology, Immunotherapy

Mikel Gurrea-Rubio

Qi Wu

M Asif Amin

Pei-Suen Tsou

Phillip L Campbell

...

2024/2

Challenges and promise of targeting miRNA in rheumatic diseases: A computational approach to identify miRNA association with cell types, cytokines, and disease mechanisms

Farheen S Shaikh

Ruby J Siegel

Aayush Srivastava

David A Fox

Salahuddin Ahmed

2024/1/9

New molecular targets in the treatment of rheumatoid arthritis

Beth I Wallace

Laura Cooney

David A Fox

2024

Rheumatoid arthritis–the challenge of heterogeneity

David A Fox

2024/5/1

CD6 triggers actomyosin cytoskeleton remodeling after binding to its receptor complex

Journal of Leukocyte Biology

Nozha Borjini

Yu Lun

Geen-Fu Jang

Jack Crabb

Yinghua Chen

...

2024/3

A CD6-targeted antibody-drug conjugate as a potential therapy for T cell–mediated disorders

JCI insight

Lingjun Zhang

Liping Luo

Jin Y Chen

Rupesh Singh

William M Baldwin III

...

2023/12/12

Reporting and Establishment of Reference Intervals for Antiphospholipid Antibody Immunoassays: A Survey of Participants in the College of American Pathologists Proficiency …

Archives of pathology & laboratory medicine

Anne E Tebo

Rohan Willis

Ann Nwosu

Christine Bashleben

David A Fox

...

2023/9/26

Herbal compound cepharanthine attenuates inflammatory arthritis by blocking macrophage M1 polarization

International Immunopharmacology

Chenyang Lu

Rui-Juan Cheng

Qiuping Zhang

Yidan Hu

Yaoyu Pu

...

2023/12/1

MOG-specific T cell response amplified in para-and post-SAR-CoV-2 infection in myelin oligodendrocyte glycoprotein antibody-associated disease

Journal of Neuroimmunology

Qi Wu

Smathorn Thakolwiboon

Ahya S Ali

Qin Wang

Deanna Dwyer

...

2023/9/15

230 Immunosuppression causes dynamic changes in expression QTLs in psoriatic skin

Journal of Investigative Dermatology

L Cooney

Q Xiao

J Mears

A Nathan

K Ishigaki

...

2023/11/1

Single-cell transcriptome analysis and protein profiling reveal broad immune system activation in IgG4-related disease

JCI insight

Chenyang Lu

Shasha Li

Pingying Qing

Qiuping Zhang

Xing Ji

...

2023/9/9

An agonistic anti-signal regulatory protein α antibody for chronic inflammatory diseases

Cell Reports Medicine

Markus M Xie

Bingbing Dai

Jason A Hackney

Tianhe Sun

Juan Zhang

...

2023/8/15

Immunosuppression causes dynamic changes in expression QTLs in psoriatic skin

Nature Communications

Qian Xiao

Joseph Mears

Aparna Nathan

Kazuyoshi Ishigaki

Yuriy Baglaenko

...

2023/10/7

Cd6 antibody for treatment of t-cell mediated diseases or disorders

2023/12/28

Intracranial calcification in systemic lupus erythematosus: a rare condition that needs more attention

Clinical and experimental rheumatology

Yidan Hu

Yangyang Zhao

Hongmei Zeng

Qiang Jin

Tian Liu

...

2023/3

CD6-targeted antibody-drug conjugate as a new therapeutic agent for T cell lymphoma

Leukemia

Neetha Parameswaran

Liping Luo

Lingjun Zhang

Joel Chen

Frank P DiFilippo

...

2023/10

Soluble CD13 induces inflammatory arthritis by activating the bradykinin receptor B1

The Journal of Clinical Investigation

Pei-Suen Tsou

Chenyang Lu

Mikel Gurrea-Rubio

Sei Muraoka

Phillip L Campbell

...

2022/6/1

Case report: IgG4-related intracranial lesions mimicking multiple sclerosis in a 14-year-old girl

Frontiers in Neurology

Pingying Qing

Chenyang Lu

Bing Yan

Chang Liu

David A Fox

...

2022/9/28

Machine-learning classification identifies patients with early systemic sclerosis as abatacept responders via CD28 pathway modulation

JCI insight

Bhaven K Mehta

Monica E Espinoza

Jennifer M Franks

Yiwei Yuan

Yue Wang

...

2022/12/12

See List of Professors in David A. Fox University(University of Michigan)

Co-Authors

H-index: 92
Kevin C. Chung, MD, MS

Kevin C. Chung, MD, MS

University of Michigan-Dearborn

H-index: 65
Thomas L Saunders

Thomas L Saunders

University of Michigan-Dearborn

H-index: 55
Michael L. Whitfield, PhD

Michael L. Whitfield, PhD

Dartmouth College

academic-engine